E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/2/2012 in the Prospect News PIPE Daily.

MedX Health announces C$1 million private placement of equity units

Non-brokered deal offers units of shares, warrants at C$0.15 apiece

By Devika Patel

Knoxville, Tenn., April 2 - MedX Health Corp. said it will conduct a C$1 million non-brokered private placement of units.

The company will sell units of one common share and one warrant at C$0.15 per unit. The one-year warrants are each exercisable at C$0.25 until May 31, 2013. The strike price is a 51.52% premium to the March 30 closing share price of C$0.165.

Settlement is expected May 31.

"This growth financing will allow MedX to deploy the capital needed to further accelerate our sales and marketing programs in North America, Europe, Australia, and entry into new geographies," president and chief executive officer Steve Guillen said in a press release. "As the leading innovator in this emerging market space, this funding will go a long way in helping us share the company's vision of becoming the premier provider of a better way to identify skin cancer early, without a surgical biopsy, and will give us the ability to immediately implement our ambitious growth plans."

Based in Mississauga, Ont., MedX Health develops phototherapy medical devices.

Issuer:MedX Health Corp.
Issue:Units of one common share and one warrant
Amount:C$1 million
Price:C$0.15
Warrants:One warrant per unit
Warrant expiration:May 31, 2013
Warrant strike price:C$0.25
Agent:Non-brokered
Pricing date:April 2
Settlement date:May 31
Stock symbol:TSX Venture: MDX
Stock price:C$0.165 at close March 30
Market capitalization:C$6 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.